Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 1/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 4/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24355511 | 0.79 | SOS1 (0.35) | SOS1 | |
| SCHEMBL19245288 | 0.75 | SSTR4 (0.41) | SOS1SSTR4BACE1PAX8 | |
| SCHEMBL10329954 | 0.74 | SOS1 (0.38) | SOS1CACNA1GCACNA1BCACNA1CPAX8 | |
| SCHEMBL1053992 | 0.73 | HSP90AA1 (0.36) | SOS1CACNA1GCACNA1BCACNA1CPAX8 | |
| SCHEMBL25371246 | 0.73 | SOS1 (0.32) | SOS1 | |
| SCHEMBL20045606 | 0.72 | HDAC1 (0.36) | SOS1SSTR4BACE1BACE2GRM2 | |
| SCHEMBL29251017 | 0.72 | SSTR4 (0.38) | SOS1SSTR4BACE1BACE2 | |
| SCHEMBL12397947 | 0.71 | NOTUM (0.47) | SOS1BACE1CACNA1GCACNA1BCACNA1C | |
| SCHEMBL31168497 | 0.71 | PAX8 (0.41) | SOS1SSTR4CACNA1GCACNA1BCACNA1C | |
| SCHEMBL27259824 | 0.71 | APP (0.34) | SSTR4BACE1CACNA1GCACNA1BCACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658647-A1 | TRICYCLIC AZEPINONE DERIVATIVES AS SYSTEM XC INHIBITORS | UCB Biopharma SRL (BE) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024160722-A1 | TRICYCLIC AZEPINONE DERIVATIVES AS SYSTEM XC INHIBITORS | UCB Biopharma SRL (BE) | 2024-08-08 | — | — | WO | disclosed |